Mayank G. Sharma
Research Subjects
Mayank G. Sharma has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Hitendra M. Patel
Department of Chemistry Sardar Patel University Vallabh Vidyanagar Gujarat India
8 shared publications - Ruturajsinh M. Vala
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Gujarat, India
7 shared publications - Divyang M. Patel
Department of Chemistry, Sankalchand Patel University, Visnagar, India
5 shared publications - Ramesh L. Gardas
Indian Institute of Technology Madras
4 shared publications - Smitkumar D. Vankar
Department of Chemical Sciences, School of Chemical & Industrial Sciences (SoCIS), GSFC University, Fertilizer Nagar, Vadodara, Gujarat–391750, India
4 shared publications - Venkatachalam Ramkumar
Indian Institute of Technology Madras
4 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Catalytic synthesis of pyrazole-4-carbonitriles: a systematic review
Pyrazole derivatives have emerged as a vital class of heterocyclic compounds due to their wide range of biological activities and promising therapeutic applications.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessCatalytic synthesis of pyrazole-4-carbonitriles: a systematic review
Pyrazole derivatives have emerged as a vital class of heterocyclic compounds due to their wide range of biological activities and promising therapeutic applications.
- 10 November 2025
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (3) , 3343-3365
The cocrystal advantage: overcoming polymorph patent barriers in generic drug development
In the pharmaceutical industry, the strategic extension of drug exclusivity through polymorph patents presents a significant barrier to the timely market entry of generic competitors. This review delineates the use of pharmaceutical cocrystals as a sophisticated strategy to navigate these intellectual property hurdles. By forming a multi-component crystalline solid with a pharmaceutically acceptable co-former, a new solid form of the active pharmaceutical ingredient (API) is created, which is structurally and legally distinct from patented polymorphs. This approach provides a dual advantage: it offers a non-infringing pathway for generic development and simultaneously presents an opportunity to enhance the API's physicochemical properties. The formation of cocrystals can lead to significant improvements in solubility, dissolution rate, stability, and bioavailability, thereby creating value-added generic products with superior performance. This article examines the interplay between the Hatch–Waxman Act, regulatory pathways such as the ANDA, and the scientific principles of crystal engineering that underpin cocrystal design and synthesis. Through case studies of recently developed cocrystals for APIs like Daprodustat, Roxadustat, and Vadadustat, we illustrate the practical application and commercial potential of this strategy. Ultimately, pharmaceutical cocrystals represent a critical convergence of materials science, regulatory law, and drug delivery, offering an innovative and effective route for accelerating patient access to affordable and improved medicines.
- 10 November 2025
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (3) , 3343-3365
The cocrystal advantage: overcoming polymorph patent barriers in generic drug development
In the pharmaceutical industry, the strategic extension of drug exclusivity through polymorph patents presents a significant barrier to the timely market entry of generic competitors. This review delineates the use of pharmaceutical cocrystals as a sophisticated strategy to navigate these intellectual property hurdles. By forming a multi-component crystalline solid with a pharmaceutically acceptable co-former, a new solid form of the active pharmaceutical ingredient (API) is created, which is structurally and legally distinct from patented polymorphs. This approach provides a dual advantage: it offers a non-infringing pathway for generic development and simultaneously presents an opportunity to enhance the API's physicochemical properties. The formation of cocrystals can lead to significant improvements in solubility, dissolution rate, stability, and bioavailability, thereby creating value-added generic products with superior performance. This article examines the interplay between the Hatch–Waxman Act, regulatory pathways such as the ANDA, and the scientific principles of crystal engineering that underpin cocrystal design and synthesis. Through case studies of recently developed cocrystals for APIs like Daprodustat, Roxadustat, and Vadadustat, we illustrate the practical application and commercial potential of this strategy. Ultimately, pharmaceutical cocrystals represent a critical convergence of materials science, regulatory law, and drug delivery, offering an innovative and effective route for accelerating patient access to affordable and improved medicines.
- Open Access
- 4 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (24) , 19069-19078
Green protocol for the synthesis of 2-amino-4H-chromene-3-carbonitrile derivatives utilizing pyridine-2-carboxylic acid as a rapid catalyst
This study investigates the green synthesis of 2-amino-4H-chromene-3-carbonitrile derivatives using pyridine-2-carboxylic acid (P2CA) as a sustainable and rapid catalyst. The reaction employs a one-pot multicomponent approach, combining various substituted aldehydes, malononitrile, and dimedone in a water–EtOH (1 : 1) solvent mixture under reflux conditions. Optimization of the reaction conditions revealed that P2CA (15 mol%) facilitated high yields of up to 98% in short reaction times while adhering to green chemistry principles. Control experiments, mechanistic studies and plausible mechanisms demonstrated the catalyst's dual acid–base behaviour, which drives the formation of intermediates and the selective generation of products. The process showed significant green metrics, including a high Atom Economy (AE) (99.36%) and a low E-factor (16.68), confirming its greenness with EcoScale of 82 (>75, excellent synthesis). Furthermore, gram-scale synthesis validated the method's scalability and potential for industrial applications, instilling confidence in its practicality and widespread use. The catalyst's recyclability was established, with consistent performance observed over four cycles. A comparative analysis with previously reported catalysts highlighted P2CA's competitive efficiency and industrial applicability. This work underscores the utility of P2CA as a versatile and sustainable catalyst, contributing to the development of eco-efficient methodologies for synthesizing 4H-chromene derivatives. The potential impact of this research is inspiring as it paves the way for more sustainable chemical synthesis practices.
- 4 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (24) , 19069-19078
Open AccessGreen protocol for the synthesis of 2-amino-4H-chromene-3-carbonitrile derivatives utilizing pyridine-2-carboxylic acid as a rapid catalyst
This study investigates the green synthesis of 2-amino-4H-chromene-3-carbonitrile derivatives using pyridine-2-carboxylic acid (P2CA) as a sustainable and rapid catalyst. The reaction employs a one-pot multicomponent approach, combining various substituted aldehydes, malononitrile, and dimedone in a water–EtOH (1 : 1) solvent mixture under reflux conditions. Optimization of the reaction conditions revealed that P2CA (15 mol%) facilitated high yields of up to 98% in short reaction times while adhering to green chemistry principles. Control experiments, mechanistic studies and plausible mechanisms demonstrated the catalyst's dual acid–base behaviour, which drives the formation of intermediates and the selective generation of products. The process showed significant green metrics, including a high Atom Economy (AE) (99.36%) and a low E-factor (16.68), confirming its greenness with EcoScale of 82 (>75, excellent synthesis). Furthermore, gram-scale synthesis validated the method's scalability and potential for industrial applications, instilling confidence in its practicality and widespread use. The catalyst's recyclability was established, with consistent performance observed over four cycles. A comparative analysis with previously reported catalysts highlighted P2CA's competitive efficiency and industrial applicability. This work underscores the utility of P2CA as a versatile and sustainable catalyst, contributing to the development of eco-efficient methodologies for synthesizing 4H-chromene derivatives. The potential impact of this research is inspiring as it paves the way for more sustainable chemical synthesis practices.
- 21 March 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (12)
Recent Advances in Catalytic Approaches for Pyrano[2,3‐c]Pyrazole Synthesis: Green and Sustainable Perspectives
This review provides a detailed look at the methods used to create pyrano[2,3‐c]pyrazole derivatives over the past ten years, with a focus on various catalytic techniques. The review highlights progress in green chemistry, showing how catalysts such as homogeneous, heterogeneous, and nanoparticle types have been used. It also discusses new approaches like microwave‐assisted and catalyst‐free synthesis. The review evaluates the effectiveness of different catalysts based on reaction efficiency, yield, and sustainability. Furthermore, it explores eco‐friendly options like bio‐catalysts and ionic liquid catalysts, which offer scalable and environmentally‐friendly methods for producing these important compounds. Pyrano[2,3‐c]pyrazoles were chosen for their significant potential in pharmaceuticals and industry. The review emphasizes how sustainable catalysts are becoming more important in modern chemistry, particularly due to their reusability and lower environmental impact, making them ideal for industrial applications.
- 21 March 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (12)
Recent Advances in Catalytic Approaches for Pyrano[2,3‐c]Pyrazole Synthesis: Green and Sustainable Perspectives
This review provides a detailed look at the methods used to create pyrano[2,3‐c]pyrazole derivatives over the past ten years, with a focus on various catalytic techniques. The review highlights progress in green chemistry, showing how catalysts such as homogeneous, heterogeneous, and nanoparticle types have been used. It also discusses new approaches like microwave‐assisted and catalyst‐free synthesis. The review evaluates the effectiveness of different catalysts based on reaction efficiency, yield, and sustainability. Furthermore, it explores eco‐friendly options like bio‐catalysts and ionic liquid catalysts, which offer scalable and environmentally‐friendly methods for producing these important compounds. Pyrano[2,3‐c]pyrazoles were chosen for their significant potential in pharmaceuticals and industry. The review emphasizes how sustainable catalysts are becoming more important in modern chemistry, particularly due to their reusability and lower environmental impact, making them ideal for industrial applications.
- 10 March 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (10)
Synthesis of Dihydropyrimidinones and Dihydropyrimidin(thio)ones in Ionic Liquid: A Systematic Review on Biginelli Reaction
The Biginelli reaction, first introduced in 1893, is a key one‐pot condensation reaction in organic chemistry that facilitates the synthesis of dihydropyrimidinones (DHPMs) and dihydropyrimidin(thio)ones (DHPMTs). Traditional methods for this reaction often face challenges such as low yields, extended reaction times, and the use of hazardous solvents. Recent advancements have introduced ionic liquids (ILs) as sustainable alternatives that act both as solvents and catalysts, enhancing reaction efficiency while adhering to green chemistry principles. This systematic review examines the role of ILs in optimizing Biginelli reactions, emphasizing their benefits in reducing reaction time, increasing yields, and allowing for recyclability. Additionally, the study assesses the ecotoxicological impact of ILs, addressing concerns regarding their long‐term environmental effects. The findings highlight ILs' potential to revolutionize heterocycle synthesis by balancing sustainability with efficiency. As research advances, the continued development of eco‐friendly ILs and innovative catalytic systems will be crucial in refining synthetic methodologies and minimizing ecological impact.
- 10 March 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (10)
Synthesis of Dihydropyrimidinones and Dihydropyrimidin(thio)ones in Ionic Liquid: A Systematic Review on Biginelli Reaction
The Biginelli reaction, first introduced in 1893, is a key one‐pot condensation reaction in organic chemistry that facilitates the synthesis of dihydropyrimidinones (DHPMs) and dihydropyrimidin(thio)ones (DHPMTs). Traditional methods for this reaction often face challenges such as low yields, extended reaction times, and the use of hazardous solvents. Recent advancements have introduced ionic liquids (ILs) as sustainable alternatives that act both as solvents and catalysts, enhancing reaction efficiency while adhering to green chemistry principles. This systematic review examines the role of ILs in optimizing Biginelli reactions, emphasizing their benefits in reducing reaction time, increasing yields, and allowing for recyclability. Additionally, the study assesses the ecotoxicological impact of ILs, addressing concerns regarding their long‐term environmental effects. The findings highlight ILs' potential to revolutionize heterocycle synthesis by balancing sustainability with efficiency. As research advances, the continued development of eco‐friendly ILs and innovative catalytic systems will be crucial in refining synthetic methodologies and minimizing ecological impact.
- 23 October 2024
- Published by Wiley in ChemistrySelect
- Vol. 9 (40)
Rapid Synthesis of Schiff Bases via Pyridine‐2‐Carboxylic Acid as an Effective Catalyst
This work focuses on the rapid synthesis of Schiff bases with green protocols, where P2CA (Pyridine‐2‐carboxylic acid) is utilized as a catalyst. The condensation reaction of aldehydes and anilines, facilitated by P2CA, resulted in the production of Schiff bases in good to excellent yield within a remarkably short time of up to 15 min. The electronic effect of the various substituents on aldehyde and aniline, in combination with the catalytic effect of P2CA, accelerated the reactions under mild conditions. The reusability of the catalyst was thoroughly examined, and the catalyst was characterized over every cycle. Importantly, this approach is not only green and sustainable, but also cost‐effective, harmless, and environmentally friendly, thanks to the affordability and benign nature of P2CA.
- 23 October 2024
- Published by Wiley in ChemistrySelect
- Vol. 9 (40)
Rapid Synthesis of Schiff Bases via Pyridine‐2‐Carboxylic Acid as an Effective Catalyst
This work focuses on the rapid synthesis of Schiff bases with green protocols, where P2CA (Pyridine‐2‐carboxylic acid) is utilized as a catalyst. The condensation reaction of aldehydes and anilines, facilitated by P2CA, resulted in the production of Schiff bases in good to excellent yield within a remarkably short time of up to 15 min. The electronic effect of the various substituents on aldehyde and aniline, in combination with the catalytic effect of P2CA, accelerated the reactions under mild conditions. The reusability of the catalyst was thoroughly examined, and the catalyst was characterized over every cycle. Importantly, this approach is not only green and sustainable, but also cost‐effective, harmless, and environmentally friendly, thanks to the affordability and benign nature of P2CA.
- 14 September 2022
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 198 (2) , 145-153
Crystal structure, antibacterial and antifungal evaluation of 5-bromothiophene based 3,4-dihydropyrimidin-2-(1H)-(thi)ones
Herein, a solvent-free synthesis of 5-bromothiophene based 3,4-dihydropyrimidin-2-(1H)-(thi)ones was explored. The main advantages of this study are that pure products are readily obtained through an easy workup and without using any separation technique and in good yields (66-80% yield), All the synthesized products were characterized by 1H and 13C-APT NMR, IR spectroscopy and elemental analysis. A single crystal X-ray analysis of ethyl-4-(5-bromothiophen-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4c) was performed. All the synthesized compounds were screened for their antifungal and antibacterial assay. Among all synthesized compounds, some showed good antibacterial and antifungal activity. ADMET prediction for was carried out and calculated data show that all the compounds have a drug-like nature.
- 14 September 2022
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 198 (2) , 145-153
Crystal structure, antibacterial and antifungal evaluation of 5-bromothiophene based 3,4-dihydropyrimidin-2-(1H)-(thi)ones
Herein, a solvent-free synthesis of 5-bromothiophene based 3,4-dihydropyrimidin-2-(1H)-(thi)ones was explored. The main advantages of this study are that pure products are readily obtained through an easy workup and without using any separation technique and in good yields (66-80% yield), All the synthesized products were characterized by 1H and 13C-APT NMR, IR spectroscopy and elemental analysis. A single crystal X-ray analysis of ethyl-4-(5-bromothiophen-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4c) was performed. All the synthesized compounds were screened for their antifungal and antibacterial assay. Among all synthesized compounds, some showed good antibacterial and antifungal activity. ADMET prediction for was carried out and calculated data show that all the compounds have a drug-like nature.
- 15 February 2021
- Published by Wiley in Archiv der Pharmazie
- Vol. 354 (6) , e2000466
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones
In this study, we report on antiproliferative benzyloxy dihydropyrimidinones (DHPMs) produced by the Biginelli reaction of benzyloxy benzaldehyde, urea, and diverse 1,3‐diones. The reaction was catalyzed by lanthanum triflate and completed within 1–1.5 h, with 74–97% yield. The antiproliferative assay was carried out for all synthesized dihydropyrimidinones against six human solid tumor cell lines. Six compounds showed good antiproliferative activity with GI50 values below 5 μM. Among all the synthesized compounds, the most potent derivative showed good antiproliferative activity against all cell lines with GI50 values in the range of 1.1–3.1 μM. These DHPMs comply with druglikeness. Furthermore, ADMET prediction and the effect of P‐glycoprotein on the antiproliferative activity were also studied. Overall, our method allows eco‐friendly access to benzyloxy DHPMs as potential anticancer drugs.
- 15 February 2021
- Published by Wiley in Archiv der Pharmazie
- Vol. 354 (6) , e2000466
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones
In this study, we report on antiproliferative benzyloxy dihydropyrimidinones (DHPMs) produced by the Biginelli reaction of benzyloxy benzaldehyde, urea, and diverse 1,3‐diones. The reaction was catalyzed by lanthanum triflate and completed within 1–1.5 h, with 74–97% yield. The antiproliferative assay was carried out for all synthesized dihydropyrimidinones against six human solid tumor cell lines. Six compounds showed good antiproliferative activity with GI50 values below 5 μM. Among all the synthesized compounds, the most potent derivative showed good antiproliferative activity against all cell lines with GI50 values in the range of 1.1–3.1 μM. These DHPMs comply with druglikeness. Furthermore, ADMET prediction and the effect of P‐glycoprotein on the antiproliferative activity were also studied. Overall, our method allows eco‐friendly access to benzyloxy DHPMs as potential anticancer drugs.
- Open Access
- 25 September 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (58) , 35499-35504
Pyridine-2-carboxylic acid as an effectual catalyst for rapid multi-component synthesis of pyrazolo[3,4-b]quinolinones
Green synthesis of pyrazolo[3,4-b]quinolinones was designed using bioproduct pyridine-2-carboxylic acid (P2CA) as a green and efficient catalyst. The multi-component reaction of aldehydes, 1,3-cyclodiones and 5-amino-1-phenyl-pyrazoles regioselectively produced pyrazolo[3,4-b]quinolinones in excellent yield (84–98%). Recyclization of the catalyst was also investigated. The electronic effect of the various substituents in aromatic rings indicated that the reaction proceeded through the carbocation intermediate. This newly designed protocol very quickly constructed products conventionally under milder conditions.
- 25 September 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (58) , 35499-35504
Open AccessPyridine-2-carboxylic acid as an effectual catalyst for rapid multi-component synthesis of pyrazolo[3,4-b]quinolinones
Green synthesis of pyrazolo[3,4-b]quinolinones was designed using bioproduct pyridine-2-carboxylic acid (P2CA) as a green and efficient catalyst. The multi-component reaction of aldehydes, 1,3-cyclodiones and 5-amino-1-phenyl-pyrazoles regioselectively produced pyrazolo[3,4-b]quinolinones in excellent yield (84–98%). Recyclization of the catalyst was also investigated. The electronic effect of the various substituents in aromatic rings indicated that the reaction proceeded through the carbocation intermediate. This newly designed protocol very quickly constructed products conventionally under milder conditions.
- 7 November 2019
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 41 (7) , 1495-1505
One-Pot Assembly for Synthesis of 1,4-Dihydropyridine Scaffold and Their Biological Applications
A one-pot procedure for the preparation of functionalized 1,4-dihydropyridines by three-component reaction using substituted heterocyclic aldehydes, ammonium acetate, and substituted β-ketoesters catalyzed by L-proline was described. Present protocol offers excellent yield up to 92%, flexibility with different substitution, convenient operation, and eco-friendliness. The synthesized products were confirmed by 1H-NMR, 13C-APT, and IR spectroscopy. Herein, final confirmation of the targeted motif was made by X-ray single-crystal analysis of representative compounds (4f, 4j, 4k, 4l, and 4o). The chemically synthesized compounds were evaluated for the antiproliferative activity by cell viability (MTT) assay and dual AO/EB (acridine orange/ethidium bromide)-staining method against human A549 lung cancer cell lines. The viability of the treated cell was evaluated adopting MTT assay. According to associated changes in cell membranes during the process of apoptosis, a clear difference was observed between normal cells, early and late apoptotic cells, and necrotic cells. All compounds were found effective against Saccharomyces cerevisiae which was confirmed by increased reactive oxygen species production and DNA damage as compared to untreated yeast cell culture. Altogether, these compounds showed promising hope for application in pharmaceutical aid against yeast infections.
- 7 November 2019
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 41 (7) , 1495-1505
One-Pot Assembly for Synthesis of 1,4-Dihydropyridine Scaffold and Their Biological Applications
A one-pot procedure for the preparation of functionalized 1,4-dihydropyridines by three-component reaction using substituted heterocyclic aldehydes, ammonium acetate, and substituted β-ketoesters catalyzed by L-proline was described. Present protocol offers excellent yield up to 92%, flexibility with different substitution, convenient operation, and eco-friendliness. The synthesized products were confirmed by 1H-NMR, 13C-APT, and IR spectroscopy. Herein, final confirmation of the targeted motif was made by X-ray single-crystal analysis of representative compounds (4f, 4j, 4k, 4l, and 4o). The chemically synthesized compounds were evaluated for the antiproliferative activity by cell viability (MTT) assay and dual AO/EB (acridine orange/ethidium bromide)-staining method against human A549 lung cancer cell lines. The viability of the treated cell was evaluated adopting MTT assay. According to associated changes in cell membranes during the process of apoptosis, a clear difference was observed between normal cells, early and late apoptotic cells, and necrotic cells. All compounds were found effective against Saccharomyces cerevisiae which was confirmed by increased reactive oxygen species production and DNA damage as compared to untreated yeast cell culture. Altogether, these compounds showed promising hope for application in pharmaceutical aid against yeast infections.